From failures to first-in-class: Using AI to rescue and reposition assets

Dr Layla Hosseini-Gerami speaks at Fierce Pharma Engage in San Diego.

Layla discussed:

• How AI is proactively sourcing assets—creating data-driven, de-risked deal flow.
• How AI can help fix toxicity issues to reposition high-potential but previously failed drugs.
• How to cut through the noise: what BD&L teams and investors should really look for in AI platforms.